23andMe Holding Co.
$0.61+100.00%(+$0.61)
TickerSpark Score
52/100
73
Valuation
40
Profitability
55
Growth
60
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ME research report →
52-Week Range1% of range
Low $0.48
Current $0.61
High $12.76
Companywww.23andme.com
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics.
- CEO
- Joseph Selsavage
- IPO
- 2020
- Employees
- 560
- HQ
- South San Francisco, CA, US
Price Chart
-93.26% · this period
Valuation
- Market Cap
- $15.31M
- P/E
- -0.09
- P/S
- 0.12
- P/B
- 0.51
- EV/EBITDA
- -0.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54.17%
- Op Margin
- -105.65%
- Net Margin
- -134.69%
- ROE
- -770.81%
- ROIC
- -212.22%
Growth & Income
- Revenue
- $189.90M · -13.54%
- Net Income
- $-280,885,000 · 57.87%
- EPS
- $-10.88 · 60.57%
- Op Income
- $-240,640,000
- FCF YoY
- -1.42%
Performance & Tape
- 52W High
- $12.76
- 52W Low
- $0.48
- 50D MA
- $1.68
- 200D MA
- $4.38
- Beta
- 1.20
- Avg Volume
- 4.10M
Get TickerSpark's AI analysis on ME
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 23, 25 | Kvarda Matthew | other | 0 |
| Mar 23, 25 | Walper Thomas B. | other | 0 |
| Feb 20, 25 | Selsavage Joseph Anthony | other | 5,654 |
| Nov 20, 24 | Selsavage Joseph Anthony | other | 5,279 |
| Oct 28, 24 | Fernandez Andre J | other | 0 |
| Oct 28, 24 | FRANKOLA JIM | other | 0 |
| Oct 28, 24 | Jensen Mark Edwin | other | 0 |
| Aug 26, 24 | SCHELLER RICHARD H | other | 658,485 |
| Aug 26, 24 | MONTGOMERY RICE VALERIE MD | other | 194,552 |
| Aug 26, 24 | MONTGOMERY RICE VALERIE MD | other | 658,485 |
Our ME Coverage
We haven't published any research on ME yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ME Report →